» Articles » PMID: 23161662

Self-evolving Oxidative Stress with Identifiable Pre- and Postmitochondrial Phases in PC12 Cells

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2012 Nov 20
PMID 23161662
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

During the neurodegenerative process in several brain diseases, oxidative stress is known to play important roles in disease severity and evolution. Although early events of stress, such as increased lipid peroxidation and decreased superoxide dismutase, are known to characterize early onsets of these diseases, little is known about the events that participate in maintaining the chronic evolving phase influencing the disease progression in neurons. Here, we used differentiated PC12 cells to identify premitochondrial and postmitochondrial events occurring during the oxidative stress cascade leading to apoptosis. Our data indicate that an acute and strong oxidative impulse (500 μM H(2)O(2), 30 min) can induce, in this model, a 24-hr self-evolving stress, which advances from a premitochondrial phase characterized by lysosomes and cathepsin B and D translocations to cytosol and early mitochondrial membrane hyperpolarization. This phase lasts for about 5 hr and is followed by a postmitochondrial phase distinguished by mitochondrial membrane depolarization, reactive oxygen species increase, caspase-9 and caspase-3 activations, and apoptosis. Inhibition of cathepsins B and D suggests that cells can be protected at the premitochondrial phase of stress evolution and that new cathepsins regulators, such as glycosaminoglycans mimetics, can be considered as new therapeutic prototypes for neurodegeneration. Insofar as early oxidative stress markers have been related to the early onset of neurodegeneration, strategies protecting cells at the premitochondrial phase of oxidative stress may have important therapeutic applications.

Citing Articles

HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.

Sepulveda-Diaz J, Naini S, Huynh M, Ouidja M, Yanicostas C, Chantepie S Brain. 2015; 138(Pt 5):1339-54.

PMID: 25842390 PMC: 5963411. DOI: 10.1093/brain/awv056.


New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.

Lehri-Boufala S, Ouidja M, Barbier-Chassefiere V, Henault E, Raisman-Vozari R, Garrigue-Antar L PLoS One. 2015; 10(1):e0116641.

PMID: 25617759 PMC: 4305359. DOI: 10.1371/journal.pone.0116641.